June 6, 2024
MILAN — Fecal microbiota transplantation (FMT), also known as intestinal microbiota transplantation, significantly reduced recurrence of hepatic encephalopathy compared with placebo in patients with cirrhosis on […]
June 6, 2024
Despite the influx of adalimumab biosimilars entering the market in 2023, Humira remains on top. As of January 2024, both high and low concentrations of Humira, […]
June 6, 2024
TOPLINE: Melatonin supplementation is linked to a reduced risk for developing age-related macular degeneration (AMD) and slowing its progression, suggesting potential as a preventive therapy. METHODOLOGY: […]
June 6, 2024
The addition of abemaciclib to fulvestrant significantly improved progression-free survival for patients with hormone receptor positive, HER2 negative advanced breast cancer who had been previously treated […]
June 6, 2024
March 2023: FDA issued a guidance for immediate implementation: Cybersecurity in Medical Devices: Refuse to Accept Policy for Cyber Devices Under Section 524B of the FD&C Act. FDA […]
June 6, 2024
Liver transplantation plus chemotherapy significantly improves overall survival in carefully selected patients with unresectable colorectal liver metastases compared with chemotherapy alone, according to the results of […]
June 6, 2024
NASHVILLE, Tennessee — Large numbers of patients with multiple sclerosis (MS) who live outside large urban centers have little, or no, access to neurologic care, new […]
June 6, 2024
Adding durvalumab as consolidation treatment following concurrent chemoradiation (cCRT) adds 2 years of life and increases progression-free survival by 24% compared with placebo, in patients with […]
June 6, 2024
Among people diagnosed with cutaneous melanoma in the United States, those who live in rural areas have significantly lower rates of survival than those who live […]